Back to Legal & General Group Plc Legal & General Group Plc

CORTCORT

Showing 8 of 31 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in Corcept Therapeutics Incorporated.

Yes. Legal & General Group holds 218,078 shares of CORT (Corcept Therapeutics), worth $19M, as of its Q2 2026 13F filing. It reduced the position by 1,602 shares (-0.7%) from Q1 2026. Legal & General Group has held CORT in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$19M

Current Shares

218,078

Total Value Change

+$6.5M

Total Shares Change

-50,928

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
218,078
-0.7%
$19M0.0%$86.95
0
2026-Q1
Decreased
219,680
-10.3%
$8.9M0.0%$40.31
0
2025-Q4
Decreased
245,009
-14.6%
$8.5M0.0%$34.80
0
2025-Q3
Decreased
286,800
-4.0%
$23.8M0.0%$83.11
0
2025-Q2
Increased
298,822
+10.6%
$21.9M0.0%$73.40
32
2025-Q1
Decreased
270,137
-2.9%
$30.9M0.0%$114.22
0
2024-Q4
Increased
278,149
+3.4%
$14M0.0%$50.39
29
2024-Q3
Increased
269,006
+2.4%
$12.4M0.0%$46.28
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used